Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Angiodynamics Inc (ANGO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Angiodynamics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1275187.
Total stock buying since 2015: $1,768,443.
Total stock sales since 2015: $209,121,060.
Total stock option exercises since 2015: $5,866,525.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 10,890 | $121,432 | 4,060 | $49,978 | 0 | $0 |
| 2024 | 32,568 | $202,847 | 0 | $0 | 84,137 | $0 |
| 2023 | 0 | $0 | 4,633 | $59,997 | 52,027 | $0 |
| 2022 | 22,083 | $416,007 | 16,013 | $363,868 | 71,952 | $523,540 |
| 2021 | 0 | $0 | 36,242 | $928,775 | 81,249 | $822,736 |
| 2020 | 41,013 | $339,901 | 0 | $0 | 0 | $0 |
| 2019 | 15,000 | $212,850 | 13,650 | $292,792 | 266,359 | $367,311 |
| 2018 | 0 | $0 | 0 | $0 | 52,206 | $639,282 |
| 2017 | 30,316 | $475,406 | 4,727,409 | $75,646,492 | 111,409 | $1,600,956 |
| 2016 | 0 | $0 | 8,690,036 | $131,443,765 | 64,576 | $797,400 |
| 2015 | 0 | $0 | 18,100 | $335,393 | 72,649 | $1,115,300 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-10 | 10,890 | $121,432 | 0 | $0 | 0 | $0 |
| 2025-01 | 0 | $0 | 4,060 | $49,978 | 0 | $0 |
| 2024-10 | 22,568 | $135,847 | 0 | $0 | 0 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 84,137 | $0 |
| 2024-04 | 10,000 | $67,000 | 0 | $0 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 52,027 | $0 |
| 2023-01 | 0 | $0 | 4,633 | $59,997 | 0 | $0 |
| 2022-10 | 11,083 | $164,967 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 5,000 | $112,200 | 65,930 | $427,490 |
| 2022-04 | 0 | $0 | 11,013 | $251,668 | 6,022 | $96,050 |
| 2022-01 | 11,000 | $251,040 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 26,242 | $724,575 | 22,748 | $379,549 |
| 2021-08 | 0 | $0 | 0 | $0 | 27,698 | $0 |
| 2021-07 | 0 | $0 | 0 | $0 | 11,452 | $167,656 |
| 2021-04 | 0 | $0 | 3,500 | $83,755 | 19,351 | $275,531 |
| 2021-01 | 0 | $0 | 6,500 | $120,445 | 0 | $0 |
| 2020-08 | 1,013 | $9,501 | 0 | $0 | 0 | $0 |
| 2020-07 | 40,000 | $330,400 | 0 | $0 | 0 | $0 |
| 2019-10 | 15,000 | $212,850 | 0 | $0 | 0 | $0 |
| 2019-08 | 0 | $0 | 0 | $0 | 6,650 | $71,022 |
| 2019-07 | 0 | $0 | 13,650 | $292,792 | 253,059 | $225,267 |
| 2019-05 | 0 | $0 | 0 | $0 | 6,650 | $71,022 |
| 2018-07 | 0 | $0 | 0 | $0 | 10,556 | $94,710 |
| 2018-06 | 0 | $0 | 0 | $0 | 41,650 | $544,572 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-10-13 | Trowbridge Stephen A (EVP and CFO) | Buy | 890 | 11.16 | 9,932 |
| 2025-10-09 | Clemmer James C (President and CEO) | Buy | 10,000 | 11.15 | 111,500 |
| 2025-01-16 | Nighan Warren Jr (SVP Quality and Regulatory) | Sale | 4,060 | 12.31 | 49,978 |
| 2024-10-10 | Nighan Warren Jr (SVP Quality and Regulatory) | Buy | 100 | 6.08 | 608 |
| 2024-10-08 | Trowbridge Stephen A (EVP and CFO) | Buy | 1,700 | 5.86 | 9,962 |
| 2024-10-07 | Nighan Warren Jr (SVP Quality and Regulatory) | Buy | 768 | 6.09 | 4,677 |
| 2024-10-07 | Clemmer James C (President and CEO) | Buy | 20,000 | 6.03 | 120,600 |
| 2024-07-17 | Piccinini Laura (SVP International) | Option Ex | 4,439 | .00 | 0 |
| 2024-07-17 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Option Ex | 6,600 | .00 | 0 |
| 2024-07-17 | Trowbridge Stephen A (EVP and CFO) | Option Ex | 11,142 | .00 | 0 |
| 2024-07-17 | Nighan Warren Jr (SVP Quality and Regulatory) | Option Ex | 5,677 | .00 | 0 |
| 2024-07-17 | Clemmer James C (President and CEO) | Option Ex | 56,279 | .00 | 0 |
| 2024-04-08 | Clemmer James C (President and CEO) | Buy | 10,000 | 6.70 | 67,000 |
| 2023-07-19 | Centea Scott (SVP/GM, VIT) | Option Ex | 3,415 | .00 | 0 |
| 2023-07-19 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Option Ex | 3,900 | .00 | 0 |
| 2023-07-19 | Trowbridge Stephen A (EVP and CFO) | Option Ex | 8,769 | .00 | 0 |
| 2023-07-19 | Helsel Dave (SVP Global Operations and R&D) | Option Ex | 4,371 | .00 | 0 |
| 2023-07-19 | Clemmer James C (President and CEO) | Option Ex | 31,572 | .00 | 0 |
| 2023-01-31 | Helsel Dave (SVP Global Operations and R&D) | Sale | 4,633 | 12.95 | 59,997 |
| 2022-10-12 | Trowbridge Stephen A (EVP and CFO) | Buy | 1,083 | 13.82 | 14,967 |
| 2022-10-10 | Clemmer James C (President and CEO) | Buy | 10,000 | 15.00 | 150,000 |
| 2022-07-29 | Helsel Dave (SVP Global Operations and R&D) | Sale | 5,000 | 22.44 | 112,200 |
| 2022-07-15 | Trowbridge Stephen A (EVP and CFO) | Option Ex | 14,758 | 15.95 | 235,390 |
| 2022-07-15 | Johnson Wesley | Option Ex | 6,022 | 15.95 | 96,050 |
| 2022-07-12 | Meteny Dennis S | Option Ex | 6,022 | 15.95 | 96,050 |
| 2022-07-07 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Option Ex | 3,104 | .00 | 0 |
| 2022-07-07 | Trowbridge Stephen A (EVP and CFO) | Option Ex | 4,188 | .00 | 0 |
| 2022-07-07 | Helsel Dave (SVP Global Operations and R&D) | Option Ex | 3,480 | .00 | 0 |
| 2022-07-07 | Nighan Warren Jr (SVP Quality and Regulatory) | Option Ex | 3,233 | .00 | 0 |
| 2022-07-07 | Clemmer James C (President and CEO) | Option Ex | 25,123 | .00 | 0 |
| 2022-04-28 | Helsel Dave (SVP Global Operations and R&D) | Sale | 3,513 | 22.44 | 78,831 |
| 2022-04-20 | Donnelly Howard W | Option Ex | 6,022 | 15.95 | 96,050 |
| 2022-04-12 | Johnson Wesley | Sale | 1,299 | 23.26 | 30,214 |
| 2022-04-11 | Johnson Wesley | Sale | 6,201 | 23.00 | 142,623 |
| 2022-01-12 | Trowbridge Stephen A (EVP and CFO) | Buy | 1,000 | 22.64 | 22,640 |
| 2022-01-11 | Clemmer James C (President and CEO) | Buy | 10,000 | 22.84 | 228,400 |
| 2021-10-20 | Helsel Dave (SVP Global Operations and R&D) | Sale | 3,494 | 27.97 | 97,727 |
| 2021-10-15 | Centea Scott (Sr. VP/GM, Global VIT) | Sale | 12,000 | 27.92 | 335,040 |
| 2021-10-15 | Centea Scott (Sr. VP/GM, Global VIT) | Option Ex | 12,000 | 16.77 | 201,240 |
| 2021-10-05 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Sale | 10,748 | 27.15 | 291,808 |
| 2021-10-05 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Option Ex | 10,748 | 16.59 | 178,309 |
| 2021-08-12 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Option Ex | 2,395 | .00 | 0 |
| 2021-08-12 | Trowbridge Stephen A (EVP and CFO) | Option Ex | 3,231 | .00 | 0 |
| 2021-08-12 | Helsel Dave (SVP Global Operations and R&D) | Option Ex | 2,685 | .00 | 0 |
| 2021-08-12 | Clemmer James C (President and CEO) | Option Ex | 19,387 | .00 | 0 |
| 2021-07-28 | Meteny Dennis S | Option Ex | 5,726 | 14.64 | 83,828 |
| 2021-07-28 | Johnson Wesley | Option Ex | 5,726 | 14.64 | 83,828 |
| 2021-04-15 | Trowbridge Stephen A (EVP and CFO) | Option Ex | 13,625 | 14.07 | 191,703 |
| 2021-04-14 | Helsel Dave (SVP Global Operations and R&D) | Sale | 3,500 | 23.93 | 83,755 |
| 2021-04-01 | Donnelly Howard W | Option Ex | 5,726 | 14.64 | 83,828 |
| 2021-01-20 | Johnson Wesley | Sale | 6,500 | 18.53 | 120,445 |
| 2020-08-11 | Trowbridge Stephen A (EVP and CFO) | Buy | 1,013 | 9.38 | 9,501 |
| 2020-07-31 | Clemmer James C (President and CEO) | Buy | 40,000 | 8.26 | 330,400 |
| 2019-10-25 | Clemmer James C (President and CEO) | Buy | 15,000 | 14.19 | 212,850 |
| 2019-08-06 | Johnson Wesley | Option Ex | 6,650 | 10.68 | 71,022 |
| 2019-07-16 | Gould Kevin J | Sale | 13,650 | 21.45 | 292,792 |
| 2019-07-16 | Gould Kevin J | Option Ex | 13,650 | 11.30 | 154,245 |
| 2019-07-12 | Campbell Chad Thomas (SVP/GM, Vascular Access) | Option Ex | 3,174 | .00 | 0 |
| 2019-07-12 | Simpson Robert Arthur (SVP/GM, Global Vascular) | Option Ex | 15,600 | .00 | 0 |
| 2019-07-12 | Trowbridge Stephen A (SVP and General Counsel) | Option Ex | 3,585 | .00 | 0 |
| 2019-07-12 | Greiner Michael (EVP and CFO) | Option Ex | 10,400 | .00 | 0 |
| 2019-07-12 | Clemmer James C (President and CEO) | Option Ex | 200,000 | .00 | 0 |
| 2019-07-12 | Gold Jeffrey | Option Ex | 6,650 | 10.68 | 71,022 |
| 2019-05-31 | Meteny Dennis S | Option Ex | 6,650 | 10.68 | 71,022 |
| 2018-07-12 | Trowbridge Stephen A (SVP and General Counsel) | Option Ex | 3,556 | .00 | 0 |
| 2018-07-06 | Gold Jeffrey | Option Ex | 7,000 | 13.53 | 94,710 |
| 2018-06-22 | Johnson Wesley | Option Ex | 14,000 | 13.53 | 189,420 |
| 2018-06-21 | Meteny Dennis S | Option Ex | 14,000 | 13.53 | 189,420 |
| 2018-06-21 | Donnelly Howard W | Option Ex | 6,650 | 10.68 | 71,022 |
| 2018-06-21 | Gold Jeffrey | Option Ex | 7,000 | 13.53 | 94,710 |
| 2017-11-21 | Donnelly Howard W | Option Ex | 14,000 | 13.53 | 189,420 |
| 2017-11-15 | Richard Stark (SVP, GM - Oncology) | Sale | 27,409 | 16.29 | 446,492 |
| 2017-11-15 | Richard Stark (SVP, GM - Oncology) | Option Ex | 27,409 | 11.28 | 309,036 |
| 2017-07-25 | Meteny Dennis S | Option Ex | 14,000 | 15.75 | 220,500 |
| 2017-07-25 | Johnson Wesley | Option Ex | 14,000 | 15.75 | 220,500 |
| 2017-07-25 | Gold Jeffrey | Option Ex | 14,000 | 15.75 | 220,500 |
| 2017-07-24 | Reed Jan Stern | Buy | 316 | 16.00 | 5,056 |
| 2017-07-21 | Clemmer James C (President and CEO) | Buy | 5,000 | 15.79 | 78,950 |
| 2017-07-21 | Donnelly Howard W | Buy | 5,000 | 15.72 | 78,600 |
| 2017-07-20 | Clemmer James C (President and CEO) | Buy | 20,000 | 15.64 | 312,800 |
| 2017-06-19 | Donnelly Howard W | Option Ex | 14,000 | 15.75 | 220,500 |
| 2017-04-12 | Navilyst Medical Co-invest, Llc (10% Owner) | Sale | 2,350,000 | 16.00 | 37,600,000 |
| 2017-04-12 | Burgstahler David F (Director) | Sale | 2,350,000 | 16.00 | 37,600,000 |
| 2017-01-13 | Laporte Steve | Option Ex | 14,000 | 15.75 | 220,500 |
| 2016-11-18 | Navilyst Medical Co-invest, Llc (10% Owner) | Sale | 2,091,294 | 15.68 | 32,791,489 |
| 2016-11-18 | Burgstahler David F (Director) | Sale | 2,091,294 | 15.68 | 32,791,489 |
| 2016-08-31 | Meteny Dennis S | Option Ex | 12,000 | 13.29 | 159,480 |
| 2016-08-31 | Gold Jeffrey | Option Ex | 12,000 | 13.29 | 159,480 |
| 2016-08-05 | Navilyst Medical Co-invest, Llc (10% Owner) | Sale | 2,241,000 | 14.62 | 32,763,420 |
| 2016-08-05 | Burgstahler David F (Director) | Sale | 2,250,000 | 14.62 | 32,895,000 |
| 2016-07-15 | Johnson Wesley | Option Ex | 12,000 | 13.29 | 159,480 |
| 2016-07-15 | Donnelly Howard W | Option Ex | 12,000 | 13.29 | 159,480 |
| 2016-07-13 | Laporte Steve | Option Ex | 12,000 | 13.29 | 159,480 |
| 2016-07-11 | Trowbridge Stephen A (SVP and General Counsel) | Option Ex | 4,576 | .00 | 0 |
| 2016-05-06 | Greiner Charles R (VP - Global Franchise) | Sale | 3,508 | 12.31 | 43,183 |
| 2016-04-25 | Trowbridge Stephen A (SVP and General Counsel) | Sale | 2,440 | 12.18 | 29,719 |
| 2016-04-21 | Trowbridge Stephen A (SVP and General Counsel) | Sale | 10,500 | 12.33 | 129,465 |
| 2015-08-05 | Trowbridge Stephen A (SVP and General Counsel) | Option Ex | 5,800 | 15.27 | 88,566 |
| 2015-08-05 | Greiner Charles R (VP - Global Franchise) | Option Ex | 14,100 | 15.27 | 215,307 |
| 2015-08-05 | Laporte Steve | Option Ex | 6,000 | 15.27 | 91,620 |
| 2015-08-05 | Meteny Dennis S | Option Ex | 6,000 | 15.27 | 91,620 |
| 2015-08-05 | Johnson Wesley | Option Ex | 6,000 | 15.27 | 91,620 |
| 2015-08-05 | Gold Jeffrey | Option Ex | 6,000 | 15.27 | 91,620 |
| 2015-07-16 | Donnelly Howard W | Option Ex | 6,000 | 15.27 | 91,620 |
| 2015-06-08 | Johnson Wesley | Option Ex | 4,649 | 16.55 | 76,940 |
| 2015-02-13 | Richard Stark (SVP, GM - Oncology) | Sale | 18,100 | 18.53 | 335,393 |
| 2015-02-13 | Richard Stark (SVP, GM - Oncology) | Option Ex | 18,100 | 15.27 | 276,387 |
Insider trading activities including stock purchases, stock sales, and option exercises of ANGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Angiodynamics Inc (symbol ANGO, CIK number 1275187) see the Securities and Exchange Commission (SEC) website.